{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:55Z","timestamp":1793726575640,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","award":["MR\/Y008405\/1"],"award-info":[{"award-number":["MR\/Y008405\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","award":["MC_PC_20061"],"award-info":[{"award-number":["MC_PC_20061"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","award":["MR\/X008029\/1"],"award-info":[{"award-number":["MR\/X008029\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI MRC","doi-asserted-by":"publisher","award":["MR\/Z504725\/1"],"award-info":[{"award-number":["MR\/Z504725\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UKRI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["305292\/Z\/23\/Z"],"award-info":[{"award-number":["305292\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218486\/Z\/19\/Z"],"award-info":[{"award-number":["218486\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103004","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:21:21Z","timestamp":1783437681000},"page":"103004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Accurately modeling RNase H-mediated antisense oligonucleotide efficacy"],"prefix":"10.1016","volume":"37","author":[{"given":"Barney","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisie R.","family":"Jaques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remya R.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Whiffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa C.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-6638","authenticated-orcid":false,"given":"Carlo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103004_bib1","first-page":"427","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.103004_bib2","first-page":"2075","article-title":"RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103004_bib3","first-page":"70","article-title":"Molecular Mechanisms of Antisense Oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2026.103004_bib4","first-page":"2529","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib5","first-page":"238","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103004_bib6","first-page":"280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103004_bib7","first-page":"1349","article-title":"Volanesorsen: First Global Approval","volume":"79","author":"Paik","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2026.103004_bib8","first-page":"1371","article-title":"Inotersen: First Global Approval","volume":"78","author":"Keam","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2026.103004_bib9","first-page":"121","article-title":"The Effects of 2\u2019-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2026.103004_bib10","first-page":"18","article-title":"Safety and Tolerability of GalNAc3-Conjugated Antisense Drugs Compared to the Same-Sequence 2\u2019-O-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data","volume":"34","author":"Baker","year":"2024","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2026.103004_bib11","first-page":"1644","article-title":"Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.103004_bib12","article-title":"ASOptimizer: Optimizing antisense oligonucleotides through deep learning for IDO1 gene regulation","volume":"35","author":"Hwang","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103004_bib13","first-page":"D304","article-title":"TarBase-v9.0 extends experimentally supported miRNA\u2013gene interactions to cell-types and virally encoded miRNAs","volume":"52","author":"Skoufos","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib14","first-page":"755","article-title":"RBP-Tar \u2013 a searchable database for experimental RBP binding sites","volume":"12","author":"Gresova","year":"2023","journal-title":"F1000Res."},{"key":"10.1016\/j.omtn.2026.103004_bib15","first-page":"26","article-title":"ViennaRNA Package 2.0","volume":"6","author":"Lorenz","year":"2011","journal-title":"Algorithms Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103004_bib16","article-title":"Ciphers and Executioners: How 3\u2032-Untranslated Regions Determine the Fate of Messenger RNAs","volume":"10","author":"Mayya","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtn.2026.103004_bib17","first-page":"2862","article-title":"Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity","volume":"28","author":"Matveeva","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib18","first-page":"5671","article-title":"RiNALMo: General-Purpose RNA Language Models Can Generalize Well on Structure Prediction Tasks","volume":"16","author":"Peni\u0107","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103004_bib19","first-page":"640","article-title":"Efficient siRNA selection using hybridization thermodynamics","volume":"36","author":"Lu","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib20","first-page":"1255","article-title":"De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy","volume":"44","author":"Barcia","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.103004_bib21","first-page":"1188","article-title":"Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy","volume":"44","author":"Heron","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.103004_bib22","first-page":"287","article-title":"Potent effect of target structure on microRNA function","volume":"14","author":"Long","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.omtn.2026.103004_bib23","first-page":"59","article-title":"Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries","volume":"16","author":"Ho","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103004_bib24","first-page":"5660","article-title":"Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation","volume":"34","author":"Shao","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib25","first-page":"237","article-title":"Rapid and scalable personalized ASO screening in patient-derived organoids","volume":"638","author":"Means","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103004_bib26","article-title":"OpenAI GPT-5 System Card","author":"Singh","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.omtn.2026.103004_bib27","first-page":"D948","article-title":"Ensembl 2025","volume":"53","author":"Dyer","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib28","first-page":"261","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103004_bib29","first-page":"3406","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib30","first-page":"5215","article-title":"Global or local? Predicting secondary structure and accessibility in mRNAs","volume":"40","author":"Lange","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103004_bib31","first-page":"1929","article-title":"Dropout: A Simple Way to Prevent Neural Networks from Overfitting","volume":"15","author":"Srivastava","year":"2014","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.omtn.2026.103004_bib32","article-title":"Adam: A Method for Stochastic Optimization","author":"Kingma","year":"2017","journal-title":"arXiv"},{"key":"10.1016\/j.omtn.2026.103004_bib33","article-title":"Human MicroRNA Targets","volume":"2","author":"John","year":"2004","journal-title":"PLoS Biol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:12:06Z","timestamp":1788880326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126001757"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103004","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accurately modeling RNase H-mediated antisense oligonucleotide efficacy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103004"}}